论文部分内容阅读
目的:观察恩格菲联合顺铂腔内注入治疗恶性胸腔积液疗效与不良反应。方法:50例恶性胸腔积液患者随机分组,治疗组25例,恩格菲联合顺铂腔内注入;对照组25例,单用顺铂腔内注入。观察其疗效,体力改善状况及不良反应。结果:治疗组与对照组比较,有效率、体力改善及不良反应有统计学差异(P<0.05或P<0.01)。结论:恩格菲联合顺铂能有效控制恶性胸腔积液,提高生活质量,减轻化疗不良反应。
Objective: To observe the curative effect and adverse reaction of enfiib in combination with cisplatin in the treatment of malignant pleural effusion. Methods: Fifty patients with malignant pleural effusion were randomly divided into treatment group (n = 25) and enfilippo combined with cisplatin (n = 30). Control group (n = 25) received cisplatin alone. Observe its efficacy, physical condition and adverse reactions. Results: Compared with the control group, the effective rate, physical improvement and adverse reactions were statistically significant (P <0.05 or P <0.01). Conclusion: Ngfi combined with cisplatin can effectively control malignant pleural effusion, improve quality of life and reduce adverse reactions of chemotherapy.